BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Cybrexa is Disrupting the ADC Market with Peptide Drug Conjugate Therapeutics

  Unlike antibody-drug conjugates (ADCs) that focus on antigens, PDCs are able to target the tumor microenvironment that has universal features across solid tumors.

  January 17, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Policy

  Pfizer Chief Predicts Pandemic’s End while Surgeon General Warns of Tough Days Ahead

  As the COVID-19 pandemic moves into its third year, at least some people think we might be seeing the light at the end of the tunnel as the disease progresses from a pandemic to an endemic stage.

  January 17, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Novo Nordisk Brokers Another Deal in Fight Against Obesity

  The Danish pharma giant is partnering with EraCal Therapeutics, to develop new obesity-related drug targets.

  January 17, 2022

   · 

  3 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Another Atopic Dermatitis Drug Hits the Market as FDA Okays Pfizer’s Cibinqo

  The approval of Cibinqo was based on data from five clinical trials of more than 1,600 people. Safety and efficacy were studied in three Phase III trials.

  January 17, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  Nearing Completion, Revolution Labs Cements Lexington’s Life Sciences Growth

  The new building is expected to be ready for occupation in the fourth quarter of 2022 and will feature purpose-built laboratory infrastructure, full-service onsite amenities and multi-functional outdoor spaces.

  January 17, 2022

   · 

  2 min read

   · 

  Alvin Clavines
• 

  Business

  GSK Rebuffs Unilever’s Offers for Consumer Healthcare Unit

  GlaxoSmithKline has declined all three of Unilever PLC’s offers to acquire its Consumer Healthcare business, saying that the proposal undervalued the division’s present and further worth.

  January 17, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Policy

  Impostors! Crime in the Time of COVID-19 Targets Life Science Industry

  While many of these scams targeted the public at large, scammers also turned their sights to those sources that would naturally be on the spot as the result of demand.

  January 17, 2022

   · 

  5 min read

   · 

  Kaylei Whalen
• 

  Business

  BioSpace Celebrates Martin Luther King, Jr. Day

  BioSpace is marking Martin Luther King, Jr. Day by sharing some of our recent coverage about what the life sciences industry is doing to address racial inequality.

  January 17, 2022

   · 

  2 min read

   · 

  BioSpace Editorial Staff
• 

  Bio NC

  BioSpace Launches 2022 Hotbed Maps to Highlight Thriving Life Sciences Clusters

  As BioSpace proudly introduces our 2022 Hotbed Maps, let’s explore the industry’s most thriving territories, research leading employers and search for relevant jobs on BioSpace.

  January 17, 2022

   · 

  6 min read

   · 

  Heather McKenzie
• 

  Policy

  “Pharma Bro” Banned from Pharma Industry, Ordered to Return $64 Million

  Martin Shkreli and his former company, Vyera Pharmaceuticals, earned a 5,000% increase on the toxoplasmosis drug, Daraprim.

  January 17, 2022

   · 

  3 min read

   · 

  Alex Keown